Additionally, most immunohistochemical studies have concluded that abnormalities in the tumor suppressor gene TP53, which functions as a regulator of the cell cycle and is associated with many human malignancies, including colorectal cancer, are usually present in localized prostate cancers with high Gleason scores (>7) [41,42,43]. Here, TP53 is linked to prostate carcinoma.